Search

everythinglearnresearchcommunity

for

Search:↓

Ozone therapy might improve cancer treatment and reduce its side effects.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Spironolactone may help reduce hair loss in androgenic alopecia.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.